Processing, Please wait...

  • Home
  • About Us
  • Search:
  • Advanced Search

Growing Science » Authors » I Made Gilang Jhuniantara

Journals

  • IJIEC (747)
  • MSL (2643)
  • DSL (668)
  • CCL (508)
  • USCM (1092)
  • ESM (413)
  • AC (562)
  • JPM (271)
  • IJDS (912)
  • JFS (91)
  • HE (32)
  • SCI (26)

Keywords

Supply chain management(166)
Jordan(161)
Vietnam(149)
Customer satisfaction(120)
Performance(113)
Supply chain(110)
Service quality(98)
Competitive advantage(95)
Tehran Stock Exchange(94)
SMEs(87)
optimization(86)
Financial performance(83)
Trust(83)
TOPSIS(83)
Sustainability(81)
Job satisfaction(80)
Factor analysis(78)
Social media(78)
Knowledge Management(77)
Artificial intelligence(77)


» Show all keywords

Authors

Naser Azad(82)
Mohammad Reza Iravani(64)
Zeplin Jiwa Husada Tarigan(63)
Endri Endri(45)
Muhammad Alshurideh(42)
Hotlan Siagian(39)
Jumadil Saputra(36)
Dmaithan Almajali(36)
Muhammad Turki Alshurideh(35)
Barween Al Kurdi(32)
Ahmad Makui(32)
Basrowi Basrowi(31)
Hassan Ghodrati(31)
Mohammad Khodaei Valahzaghard(30)
Sautma Ronni Basana(29)
Shankar Chakraborty(29)
Ni Nyoman Kerti Yasa(29)
Sulieman Ibraheem Shelash Al-Hawary(28)
Prasadja Ricardianto(28)
Haitham M. Alzoubi(27)


» Show all authors

Countries

Iran(2183)
Indonesia(1290)
India(787)
Jordan(786)
Vietnam(504)
Saudi Arabia(453)
Malaysia(441)
United Arab Emirates(220)
China(206)
Thailand(153)
United States(111)
Turkey(106)
Ukraine(104)
Egypt(98)
Canada(92)
Peru(88)
Pakistan(85)
United Kingdom(80)
Morocco(79)
Nigeria(78)


» Show all countries
Sort articles by: Volume | Date | Most Rates | Most Views | Reviews | Alphabet
1.

Detecting fraudulent financial statements in pharmaceutical companies: Fraud pentagon theory perspective Pages 1611-1620 Right click to download the paper Download PDF

Authors: Dodik Ariyanto, I Made Gilang Jhuniantara, Ni Made Dwi Ratnadi, I Gusti Ayu Made Asri Dwija Putri, Ayu Aryista Dewi

DOI: 10.5267/j.ac.2021.5.009

Keywords: Fraud, Financial statement, Pharmaceutical companies, Covid-19 pandemic

Abstract:
A fraudulent financial statement is an issue that continues to be discussed as a form of deviation from corporate governance. Covid-19 pandemic has also demanded management to uphold the company's performance to have a good public image. Thus, the present study sets out to scrutinize the fraud pentagon theory on fraudulent financial statements. Each element is not able to be tested directly. However, there are proxies. The pressure element is proxied as a personal financial need. The opportunity is becoming the nature of industry. Each of the qualities of the external auditors as well as the change of directors propose rationalization and competence. The frequent number of CEO’s appearances in photos is a proxy of arrogance. The testing was carried out on the registered pharmaceutical companies of the Indonesian stock exchange in the span of the 2015-2019 period. The samples were selected by the means of sampling technique which is purposive. Data are scrutinized by the means of panel data regression. The analysis results show that the characteristics of the industry positively affects financial reports which are fraudulent. Changing top management positions such as directors can be an indication of financial reports which are fraudulent. The personal financial need variables, the caliber of external auditors and the quantity of CEO’s appearance in photos pose no effects on the fraudulent financial statements of the Indonesian's pharmaceutical companies.
Details
  • 17
  • 1
  • 2
  • 3
  • 4
  • 5

Journal: AC | Year: 2021 | Volume: 7 | Issue: 7 | Views: 1993 | Reviews: 0

 

® 2010-2026 GrowingScience.Com